BioPlus Acquisition Corp. is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It is focused on identifying an opportunity in the life sciences industry across the US, EU, Israel, and Australasia(1) Its leadership and board differentially consists of recognized industry leaders, including CEOs, CFOs, COOs, CSOs, Auditors, Investors, Bankers and experts covering all functional disciplines needed to maximize the value creation opportunity for a life sciences company. BioPlus brings over 200 years of collective experience in: 1) Identifying, developing and marketing value creating biotech assets, 2) Private and public company financing and dealmaking, 3) Audit and accounting, and 4) Advisory and board experience. BioPlus believes its team has demonstrated commitment to building valuable assets and can be leveraged as true long-term partners who can help maximize the value creation opportunity for a potential business combination.